JG
THC icon

Jefferies Group’s Tenet Healthcare THC Stock Holding History

Jefferies Group’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.92M Buy
37,301
+22,702
+156% +$1.35M 0.02% 623
2022
Q2 		$767K Buy
14,599
+6,879
+89% +$479K 0.01% 869
2022
Q1 		$664K Sell
7,720
-11,030
-59% -$906K ﹤0.01% 986
2021
Q4 		$1.53M Buy
+18,750
New +$1.37M 0.01% 879
2021
Q2 		– Sell
-15,016
Closed -$781K – 1980
2021
Q1 		$781K Buy
+15,016
New +$759K 0.01% 973
2019
Q2 		– Sell
-15,770
Closed -$455K – 2861
2019
Q1 		$455K Buy
+15,770
New +$389K ﹤0.01% 1637
2018
Q2 		– Sell
-50,776
Closed -$1.23M – 2669
2018
Q1 		$1.23M Sell
50,776
-12,132
-19% -$242K 0.01% 1109
2017
Q4 		$954K Sell
62,908
-146,763
-70% -$2.07M ﹤0.01% 1392
2017
Q3 		$3.44M Buy
209,671
+78,024
+59% +$1.32M 0.02% 679
2017
Q2 		$2.55M Buy
131,647
+6,038
+5% +$105K 0.02% 840
2017
Q1 		$2.23M Sell
125,609
-7,892
-6% -$146K 0.02% 856
2016
Q4 		$1.98M Buy
133,501
+63,552
+91% +$1.14M 0.01% 955
2016
Q3 		$1.58M Buy
69,949
+22,934
+49% +$597K 0.01% 1047
2016
Q2 		$1.3M Sell
47,015
-28,336
-38% -$837K 0.01% 1058
2016
Q1 		$2.18M Sell
75,351
-25,406
-25% -$661K 0.01% 805
2015
Q4 		$3.05M Sell
100,757
-16,596
-14% -$544K 0.02% 676
2015
Q3 		$4.33M Buy
117,353
+94,631
+416% +$4.89M 0.02% 551
2015
Q2 		$1.32M Sell
22,722
-98
-0.4% -$5.01K 0.01% 1124
2015
Q1 		$1.13M Sell
22,820
-6,227
-21% -$291K 0.01% 991
2014
Q4 		$1.47M Buy
29,047
+19,613
+208% +$1.03M 0.01% 825
2014
Q3 		$560K Sell
9,434
-11,567
-55% -$645K ﹤0.01% 1281
2014
Q2 		$986K Buy
21,001
+15,846
+307% +$716K 0.01% 907
2014
Q1 		$221K Buy
5,155
+1,276
+33% +$56.3K ﹤0.01% 1690
2013
Q4 		$164K Sell
3,879
-25,232
-87% -$1.1M ﹤0.01% 1637
2013
Q3 		$1.2M Buy
+29,111
New +$1.22M 0.01% 831

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return

Jefferies Group's THC Position: Q3 2022 in Review

Jefferies Group increased its Tenet Healthcare (THC) stake by 156% in Q3 2022, buying an estimated $1.35M and bringing the position to 37,301 shares worth $1.92M. The position accounts for 0.02% of the portfolio, ranked #623.

Jefferies Group first reported a position in THC in Q3 2013 and has held it in 25 quarters since. The position peaked at $4.33M in Q3 2015. 362 funds tracked by Wall St. Rank hold THC as of Q3 2022.

  • Jefferies Group held 37,301 shares of Tenet Healthcare worth $1.92M as of Q3 2022.
  • Jefferies Group bought 22,702 Tenet Healthcare shares in Q3 2022, an estimated $1.35M.
  • Tenet Healthcare made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #623 holding.
  • Jefferies Group first reported a position in Tenet Healthcare in Q3 2013 and has held it in 25 quarters since.
  • Jefferies Group's Tenet Healthcare position peaked at $4.33M in Q3 2015.
  • 362 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.